Blossom Health is a New York-based, AI-native psychiatry company building an AI 'copilot' and operating system for mental health care. Its premise is that AI finally makes it possible to scale high-quality psychiatric care without simply adding more staff, by augmenting clinicians with AI that handles documentation, workflow, and support tasks across the patient journey.
The company offers in-network coverage with major insurers and markets average copays around $22, positioning itself as an accessible, insurance-friendly telepsychiatry platform. Blossom says its tools are already used by hundreds of clinicians treating more than 10,000 patients across multiple states.
In March 2026, Blossom Health raised $20M in combined seed and Series A funding led by Headline, with participation from Village Global, TA Ventures, Operator Partners, and Correlation Ventures, plus a roster of operator angels from companies like Flatiron Health and Sword Health. Headline co-founder Mathias Schilling joined the board.
Blossom Health was founded by John Zhao (CEO). The company sits in the fast-growing intersection of AI and behavioral health, focusing specifically on psychiatry workflows and clinician augmentation at national scale.